Add like
Add dislike
Add to saved papers

Congenital abnormalities of the femur and related lower extremity malformations: classification and treatment.

Congenital abnormalities of the femur vary from a deficiency of the entire femur with abnormal development of the pelvis to a hypoplastic femur of normal configuration. Previous classification systems that have focused on either congenital coxa vara, hypoplastic femur, or proximal femoral focal deficiency provide a limited definition of congenital abnormalities and are included within the combined classification system outlined in this text. This system, based on embryological, teratological, biological, and anatomical considerations of 125 patients with 139 affected femora, classifies deficiencies of the proximal end, middle, and distal end of the femur and associated lower extremity abnormalities. Unlike previous classification systems, congenital femoral abnormalities principally involving the middle and distal end of the femur are recognized in distinct classes when appropriate. Associated abnormalities range from severe growth retardation of the tibia and an absent fibula accompanied by a deficiency of ischiopubic structures with an absent acetabulum to a mild tibial and fibular growth retardation. Treatment objectives include pelvic-femoral stability, prosthetic management, extremity length equality, knee stability, ankle and foot stability, and anatomical alignment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app